110 related articles for article (PubMed ID: 9155982)
1. Pyoderma gangrenosum in myelodysplasia responding to granulocyte macrophage-colony stimulating factor (GM-CSF).
Bulvik S; Jacobs P
Br J Dermatol; 1997 Apr; 136(4):637-8. PubMed ID: 9155982
[No Abstract] [Full Text] [Related]
2. Bullous pyoderma gangrenosum in a patient with myelodysplastic syndrome during granulocyte colony-stimulating factor therapy.
Lewerin C; Mobacken H; Nilsson-Ehle H; Swolin B
Leuk Lymphoma; 1997 Aug; 26(5-6):629-32. PubMed ID: 9389372
[TBL] [Abstract][Full Text] [Related]
3. [Pyoderma gangrenosum aggravated by GM-CSF administration].
Perrot JL; Benoit F; Segault D; Jaubert J; Guyotat D; Claudy A
Ann Dermatol Venereol; 1992; 119(11):846-8. PubMed ID: 1301698
[No Abstract] [Full Text] [Related]
4. Successful use of etoposide for pyoderma gangrenosum associated with myelodysplastic syndrome and trisomy 8: cytokine profiles during treatment.
Fujiwara D; Hamada T; Yamasaki O; Sando Y; Saeki K; Fujii N; Kawakami Y; Iwatsuki K
Eur J Dermatol; 2017 Oct; 27(5):525-527. PubMed ID: 28943508
[No Abstract] [Full Text] [Related]
5. An assessment of erythroid response to epoetin alpha as a single agent versus in combination with granulocyte- or granulocyte-macrophage-colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approach.
Mundle S; Lefebvre P; Vekeman F; Duh MS; Rastogi R; Moyo V
Cancer; 2009 Feb; 115(4):706-15. PubMed ID: 19152429
[TBL] [Abstract][Full Text] [Related]
6. Pyoderma gangrenosum following cytosine arabinoside, aclarubicin and granulocyte colony-stimulating factor combination therapy in myelodysplastic syndrome.
Takagi S; Ohsaka A; Taguchi H; Kusama H; Matsuoka T
Intern Med; 1998 Mar; 37(3):316-9. PubMed ID: 9617871
[TBL] [Abstract][Full Text] [Related]
7. Pyoderma gangrenosum with myelodysplastic syndrome treated with analogous bone marrow transplantation.
Yamanaka K; Kuniyuki S; Maekawa N; Yoshida Y; Teshima H
Acta Derm Venereol; 2009; 89(1):105-6. PubMed ID: 19197560
[No Abstract] [Full Text] [Related]
8. Pyoderma Gangrenosum After Total Hip Arthroplasty Associated with Administration of Granulocyte Colony-Stimulating Factor: A Case Report.
Mizushima M; Miyoshi H; Yonemori K
JBJS Case Connect; 2021 Apr; 11(2):. PubMed ID: 33878038
[TBL] [Abstract][Full Text] [Related]
9. Pyoderma gangrenosum: an inflammatory ulcer.
Samuel J; Williams C
J Wound Care; 1996 Jul; 5(7):314-8. PubMed ID: 8954419
[No Abstract] [Full Text] [Related]
10. A case report of cyclic neutropenia associated with pyoderma gangrenosum.
Jabbari H; Payvarmehr F; SeyedAlinaghi S; Roosta N
Acta Med Iran; 2011; 49(11):763-5. PubMed ID: 22131249
[TBL] [Abstract][Full Text] [Related]
11. Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes.
Nagler A; Ginzton N; Negrin R; Bang D; Donlon T; Greenberg P
Leukemia; 1990 Mar; 4(3):193-202. PubMed ID: 1690318
[TBL] [Abstract][Full Text] [Related]
12. c-kit ligand augments granulocyte-macrophage colony growth from patients with 5q- syndrome.
Rosenfeld CS; Nemunaitis J; Sherer CR; Zeigler ZR; Shadduck RK
Stem Cells; 1993 Nov; 11(6):562-7. PubMed ID: 7509225
[TBL] [Abstract][Full Text] [Related]
13. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
Visani G; Tosi P; Finelli C; Gamberi B; Zauli G; Cenacchi A; Fogli M; Colombini R; Tura S
Haematologica; 1992; 77(2):142-5. PubMed ID: 1383105
[TBL] [Abstract][Full Text] [Related]
14. [Lung abscess secondary to neutropenic myelodysplasia treated with G-CSF].
Guilleminault L; Espanel C; Marcq M; Azzouz M; Diot E; Binet C; Diot P
Rev Mal Respir; 2009 Jan; 26(1):87-9. PubMed ID: 19212297
[No Abstract] [Full Text] [Related]
15. Successful treatment for perinephric abscess with recombinant human granulocyte colony-stimulating factor following nephrectomy in a patient of myelodysplastic syndrome: a case report.
Tamura K; Takeuchi M; Hirakawa N; Toyoda K; Minoda M
Biotherapy; 1990; 2(3):223-6. PubMed ID: 1698422
[TBL] [Abstract][Full Text] [Related]
16. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes.
Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Furusawa S; Miura Y; Takaku F; Saito M
Clin Exp Immunol; 1993 Feb; 91(2):308-13. PubMed ID: 7679062
[TBL] [Abstract][Full Text] [Related]
17. Hemophagocytosis exacerbated by G-CSF/GM-CSF treatment in a patient with myelodysplasia.
Wang S; Degar BA; Zieske A; Shafi NQ; Rose MG
Am J Hematol; 2004 Dec; 77(4):391-6. PubMed ID: 15551287
[TBL] [Abstract][Full Text] [Related]
18. Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment.
Ross HJ; Moy LA; Kaplan R; Figlin RA
Cancer; 1991 Jul; 68(2):441-3. PubMed ID: 1712666
[TBL] [Abstract][Full Text] [Related]
19. Treatment of anemia in myelodysplastic syndrome with darbepoetin and granulocyte colony stimulating factor.
Rose S; Ali Y; Maffei B; Saidi P
Am J Hematol; 2007 Mar; 82(3):245-6. PubMed ID: 16924646
[No Abstract] [Full Text] [Related]
20. Treatment of myelodysplastic syndromes with hematopoietic growth factors.
Ganser A; Hoelzer D
Hematol Oncol Clin North Am; 1992 Jun; 6(3):633-53. PubMed ID: 1377194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
